IKZF1 Antikörper (AA 415-444)
Kurzübersicht für IKZF1 Antikörper (AA 415-444) (ABIN7874881)
Target
Alle IKZF1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 415-444
-
Verwendungszweck
- IKAROS Antibody / IKZF1
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- A portion of amino acids 415-444 from the human protein was used as the immunogen for the IKAROS antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting points. Titration of the IKAROS antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the IKAROS antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- IKZF1 (IKAROS Family Zinc Finger 1 (Ikaros) (IKZF1))
-
Andere Bezeichnung
- IKAROS
-
Hintergrund
- Plays a role in the development of lymphocytes, B- and T-cells. Binds and activates the enhancer (delta-A element) of the CD3-delta gene. Repressor of the TDT (fikzfterminal deoxynucleotidyltransferase) gene during thymocyte differentiation. Regulates transcription through association with both HDAC-dependent and HDAC-independent complexes. Targets the 2 chromatin-remodeling complexes, NuRD and BAF (SWI/SNF), in a single complex (PYR complex), to the beta-globin locus in adult erythrocytes. Increases normal apoptosis in adult erythroid cells. Confers early temporal competence to retinal progenitor cells (RPCs) (By similarity). [UniProt]
-
UniProt
- Q13422
-
Pathways
- Production of Molecular Mediator of Immune Response
Target
-